---
document_datetime: 2024-03-12 15:24:22
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/prevenar-20-previously-apexxnar-epar-all-authorised-presentations_en.pdf
document_name: prevenar-20-previously-apexxnar-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.8333566
conversion_datetime: 2025-12-18 22:38:45.005724
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form      | Route of administration   | Immediate Packaging        | Content (concentration)   | Pack size                           |
|------------------|-------------------|------------|--------------------------|---------------------------|----------------------------|---------------------------|-------------------------------------|
| EU/1/21/1612/001 | Prevenar 20       | --¹        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 1 pre-filled syringe                |
| EU/1/21/1612/002 | Prevenar 20       | --¹        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 1 pre-filled syringe + 1 needle     |
| EU/1/21/1612/003 | Prevenar 20       | --¹        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 10 pre-filled syringes              |
| EU/1/21/1612/004 | Prevenar 20       | --¹        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 10 pre-filled syringes +10 needles  |
| EU/1/21/1612/005 | Prevenar 20       | --¹        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 50 pre-filled syringes              |
| EU/1/21/1612/006 | Prevenar 20       | --¹        | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 50 pre-filled syringes + 50 needles |

--¹

--¹

| 1 dose (0.5 mL) contains:                   |        |
|---------------------------------------------|--------|
| Pneumococcal polysaccharide serotype 1¹ ²   | 2.2 μg |
| Pneumococcal polysaccharide serotype 3¹ ²   | 2.2 μg |
| Pneumococcal polysaccharide serotype 4¹ ²   | 2.2 μg |
| Pneumococcal polysaccharide serotype 5¹ ²   | 2.2 μg |
| Pneumococcal polysaccharide serotype 6A¹ ²  | 2.2 μg |
| Pneumococcal polysaccharide serotype 6B¹ ²  | 4.4 μg |
| Pneumococcal polysaccharide serotype 7F¹ ²  | 2.2 μg |
| Pneumococcal polysaccharide serotype 8¹ ²   | 2.2 μg |
| Pneumococcal polysaccharide serotype 9V¹ ²  | 2.2 μg |
| Pneumococcal polysaccharide serotype 10A¹ ² | 2.2 μg |
| Pneumococcal polysaccharide serotype 11A¹ ² | 2.2 μg |
| Pneumococcal polysaccharide serotype 12F¹ ² | 2.2 μg |
| Pneumococcal polysaccharide serotype 14¹ ²  | 2.2 μg |
| Pneumococcal polysaccharide serotype 15B¹ ² | 2.2 μg |
| Pneumococcal polysaccharide serotype 18C¹ ² | 2.2 μg |
| Pneumococcal polysaccharide serotype 19A¹ ² | 2.2 μg |
| Pneumococcal polysaccharide serotype 19F¹ ² | 2.2 μg |
| Pneumococcal polysaccharide serotype 22F¹ ² | 2.2 μg |
| Pneumococcal polysaccharide serotype 23F¹ ² | 2.2 μg |
| Pneumococcal polysaccharide serotype 33F¹ ² | 2.2 μg |

¹ Conjugated to CRM₁₉₇ carrier protein (approximately 51 μg per dose)

² Adsorbed on aluminium phosphate (0.125 mg aluminium per dose)